Award details

125 dihydroxyvitamin D3 HOXA10 and fetal implantation: a novel role for extra-renal expression of 1alpha hydroxylase

ReferenceS14523
Principal Investigator / Supervisor Professor Martin Hewison
Co-Investigators /
Co-Supervisors
Dr Judith Bulmer, Professor Mark Kilby
Institution University of Birmingham
DepartmentMedical Sciences - Medicine
Funding typeResearch
Value (£) 210,248
StatusCompleted
TypeResearch Grant
Start date 01/10/2001
End date 01/10/2004
Duration36 months

Abstract

The immunological nature of fetal implantation is illustrated by the repertoire of haematopoietic cell sub-sets within the decidua. Furthermore, both trophoblastic and decidual cells express the enzyme lalpha- hydroxylase (1-HYD) which catalyzes synthesis of active vitamin D 1,25-dihydroxyvitamin D3 (1,25D3), a potent immunosuppressive steroid hormone. The proposed project will address the hypothesis that production of 1,25D3 by macrophage-like cells in human decidua plays an important role in implantation by regulating expression of the homeobox, HOXA10 gene in an autocrine/paracrine fashion. Human tissue analysis, flow cytometry and in vitro models will be used to determine the relationship between HOXA10 and 1,25D3 in implantation.

Summary

unavailable
Committee Closed Committee - Animal Sciences (AS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file